Upload
allie
View
30
Download
1
Embed Size (px)
DESCRIPTION
Health Care Effectiveness Clinical Excellence. January 25, 2011. “We are what we repeatedly do. Excellence, then, is not an act, but a habit.” Aristotle. Diabetes Clinical Excellence Award. Award Recipient. Leonard J Chabert Medical Center. Diabetes Clinical Lead Award. - PowerPoint PPT Presentation
Citation preview
Health Care Effectiveness Clinical Excellence
January 25, 2011
“We are what we repeatedly do. Excellence, then, is not an act, but
a habit.”
Aristotle
DiabetesClinical Excellence Award
Award Recipientcriterion BMC EKL ILH LAK LJC UMC WOM
%cases w/glucose ever < 50 0.05 0.06 0.02 0.03 0.00 0.04 0.07 0.00
%cases w/glucose ever < 70 0.15 0.15 0.11 0.13 0.06 0.12 0.21 0.07
%time 70 < glucose < 180 0.60 0.51 0.60 0.63 0.51 0.60 0.60 0.43
Eye exam in past 15 mos 0.55 0.49 0.62 0.51 0.42 0.62 0.65 0.41
HbA1c 9 mos <= 7% 0.55 0.55 0.47 0.45 0.59 0.58 0.56 0.52
HbA1c in past 9 months 0.80 0.75 0.84 0.81 0.77 0.87 0.81 0.81
LDL 15 mos <= 100 0.55 0.58 0.58 0.63 0.49 0.61 0.62 0.55
LDL test in past 15 mos 0.85 0.84 0.87 0.89 0.81 0.86 0.88 0.85
last BP <= 130/80 0.40 0.34 0.31 0.37 0.31 0.40 0.35 0.40
Leonard J Chabert Medical Center
DiabetesClinical Lead Award
Heart Failure Clinical Excellence Award
Award Recipient
University Medical Center
Leonard J Chabert Medical Center
Lallie Kemp Medical Center
Bogalusa Medical Center
criterion BMC EKL ILH LAK LJC UMC WOMOn ACE/ARB 0.85 0.95 0.87 0.92 0.90 0.96 0.92 0.85On NSAID 0.05 0.00 0.02 0.01 0.01 0.02 0.01 0.04last < 130/80, weighted 0.50 0.50 0.44 0.53 0.50 0.56 0.53 0.43on metop-s, carvedilol, or bisoprolol 0.85 0.85 0.86 0.85 0.85 0.96 0.90 0.85pneumovax ever 0.70 0.92 0.91 0.68 0.76 0.94 0.92 0.90
Heart Failure Clinical Lead Award
Asthma Clinical Excellence Award
Award Recipient
Bogalusa Medical Center
Earl K Long Medical Center
WO Moss Regional Medical Center
criterion BMC EKL ILH LAK LJC UMC WOM% on ICS or ICS/LABA in pers/sevr 0.80 0.92 0.98 0.98 0.91 0.96 0.90 0.80
% with PFT in past 3 yrs 0.70 0.70 0.75 0.65 0.59 0.60 0.51 0.80
Asthma Clinical Lead Award
HIV Clinical Excellence Award
Award Recipient
Leonard J Chabert Medical Center
Interim LSU Public Hospital
WO Moss Regional Medical Center
criterion BMC EKL ILH LAK LJC UMC WOMCD4, CD4 test in past 15 mos 0.90 0.95 0.99 0.99 0.99 0.98 0.99 0.94PCP prophylaxis, CD4 < 200 sustained 0.90 1.00 0.95 0.92 0.80 1.00 0.87 0.94STDs, Chlamydia test in past 15 mos 0.80 0.73 0.77 0.83 0.60 0.93 0.86 0.86STDs, Gonorrhea test in past 15 mos 0.80 0.73 0.77 0.83 0.60 0.93 0.86 0.86viral load test in past year 0.90 0.96 0.98 0.99 0.97 0.98 0.98 0.92
HIV Clinical Lead Award
HOP – a TRRRAQSSS Clinic
• Teaching –– 54 Tulane and 44 LSU Fellows to date– 10 Research Fellows – 5 PhD’s from HOP database
• Research: participated in > 400 studies• Revenue: program grants $2,244,000/y
– 1990’s, saved $millions in cost of HIV meds
• Resources: one-stop shop model– on-site subspecialists, HE, social work
• Access: < 24 h to next Phase I appt
Chronic Kidney Disease Clinical Excellence Award
Award Recipient
University Medical Center
criterion BMC EKL ILH LAK LJC UMC WOM
ANEMIA, HGB < 10, stage 3conf, stan 0.20 0.04 0.05 0.05 0.04 0.06 0.05 0.05
ANEMIA, HGB < 10, stage 4conf, stan 0.20 0.13 0.24 0.20 0.05 0.21 0.15 0.09
BP, last BP < 130/80, stage 34conf, stan 0.40 0.28 0.35 0.38 0.34 0.39 0.40 0.33
CONF, % confirmed among overdue 0.30 0.43 0.49 0.58 0.61 0.60 0.58 0.40
LIPIDS, HDL > 40, stage 34conf, stan 0.40 0.46 0.45 0.47 0.46 0.42 0.46 0.43
LIPIDS, LDL < 100, stage 34conf, stan 0.65 0.59 0.66 0.60 0.53 0.61 0.66 0.52
LIPIDS, TRIG < 150, stage 34conf, stan 0.60 0.66 0.62 0.67 0.68 0.67 0.70 0.57
PHOS, 2.7 < PHOS < 4.6, stage3conf 0.70 0.90 0.85 0.90 0.93 0.90 0.90 0.91
PHOS, 2.7 < PHOS < 4.6, stage4conf 0.70 0.86 0.87 0.87 0.86 0.84 0.79 1.00
Chronic Kidney Disease Clinical Lead Award
Cancer Screening Clinical Excellence Award
Award Recipient
Bogalusa Medical Center
criterion BMC EKL ILH LAK LJC UMC WOM
Mammogram in past 2 years, age 40-75 0.80 0.82 0.81 0.78 0.85 0.87 0.83 0.88
PSA in past 2 years, age 50-75 0.80 0.89 0.78 0.80 0.87 0.91 0.79 0.85
Pap in 2 yrs (21-29) or 3 yrs (30-69) 0.80 0.80 0.66 0.74 0.44 0.83 0.76 0.65
Scope_10yr OR flexsig_5yr OR FOBT_1yr 0.50 0.53 0.37 0.34 0.48 0.47 0.38 0.33
Cancer Screening Clinical Lead Award
Weight ManagementClinical Lead Award
Tobacco Cessation Clinical Excellence Award
Award Recipient
Bogalusa Medical Center
Leonard J Chabert Medical Center
Lallie Kemp Medical Center
criterion BMC EKL ILH LAK LJC UMC WOM
% advised 0.90 0.97 0.93 0.96 0.96 0.98 0.96 0.97
% assessed readiness to quit 0.90 0.97 0.93 0.96 0.96 0.98 0.97 0.97% selected assistance among smokers ready to quit 0.70 0.97 0.68 0.66 0.96 0.92 0.78 0.91
screening rate in past 90 days 0.90 0.98 0.86 0.89 0.99 0.93 0.88 0.86
Tobacco Cessation Clinical Lead Award
Emergency DepartmentClinical Excellence Award
Award Recipient
Bogalusa Medical Center
Lallie Kemp Medical Center
BMC EKL ILH LAK LJC UMC WOM
Door to Doctor - Home 67 77 75 74 72 95 108
Doc to Discharge - Home 87 106 115 76 100 72 68
LOS - Home 157 206 233 175 197 195 202
LWOBS 5% 7% 9% 5% 4% 8% 9%
Emergency DepartmentClinical Lead Award
HypertensionClinical Lead Award
Congratulations to All Award Recipients